Of the 100 patients initially enrolled in the study, 11 were classified as dropouts due to being lost to follow-up, while 4 patients discontinued treatmentone due to hypoglycemia, one due to lack of efficacy, and two due to challenges in accessing the medicationresulting in 85 patients completing therapy until the studys conclusion
Retatrutide: Weekly injection per standard escalation protocol BPC-157: 0.25 to 0.5 mg daily, subcutaneous TB-500 Loading (Weeks 1-4): 2.5 mg Monday and Thursday TB-500 Maintenance (Weeks 5+): 2 mg every 7 to 14 days Total Duration: 6 to 8 weeks with 4 weeks off before repeating The GLOW Protocol: Triple Healing Power The GLOW protocol extends the Wolverine Stack by adding GHK-Cu, creating a comprehensive regeneration stack that addresses healing, inflammation, and skin health simultaneously
The complete week-by-week retatrutide timeline The following timeline draws from phase 2 trial data involving 338 adults published in the New England Journal of Medicine, phase 3 data from Eli Lilly announcements, and the published qualitative study on participant experiences during the clinical trial
Do I need to store these peptides differently
Beyond the Gut: The Brain Connection There is one more incredible benefit to BPC-157
Hamilton RA, Briceland LL, Andritz MH
